EMPEA Private Equity Masterclass in Hong Kong
The Offices of Debevoise & Plimpton | 21/F AIA Central, 1 Connaught Road, Central, Hong Kong
EMPEA and HKVCA members may register for free with the code EMPEAHK18.
EMPEA’s 4th Private Equity Masterclass in Hong Kong will take place on Thursday, 18 January 2018 following the Asian Financial Forum and the Asia Private Equity Forum on 17 January.
In both size and scope, the private capital industry in Emerging Asia increasingly looks more like a developed market than an emerging market. Fund managers have invested US$27 billion in Emerging Asia so far this year, removing any doubt that 2017 year-end totals will surpass 2014’s previous record of US$28 billion. At a scale more commonly seen in the U.S. or Western Europe, big-ticket buyouts and expansive growth deals drove investment totals, particularly in China and South Korea. Concurrently, larger funds have raised an outsized proportion of Emerging Asia’s fundraising. Five funds accounted for 54% of the US$26 billion raised so far in 2017, including the record-breaking US$9.3 billion KKR Asian Fund III, which closed in June. Capital concentration in a small number of funds will likely increase as global LPs looking to enter the region commit to well-established managers. However, venture capital funds accounted for 58% of funds closed in 2017, indicating that small—and often local—funds with access to Asia’s most promising startups still play an important role in the industry.
Speakers (more to be added)
Karlyn Adams, Associate Director, BSR
Karlyn Adams, an Associate Director in BSR’s Hong Kong office, focuses on helping companies and investors to integrate environmental, social and governance considerations into their business models and processes. Her work is cross-industry with emphasis on financial services, consumer goods, and transportation & logistics. Prior to joining BSR, Karlyn was VP of Strategy & Transformation for TAU Investment Management, a private equity firm focused on investing in manufacturers in Asia, and founded on principles of ESG integration and responsible supply chains. She was formerly a management consultant with IBM and with the Boston Consulting Group (BCG) where she advised corporate clients in financial services, pharma and high tech on a range of topics requiring strategic analysis, creative problem-solving, stakeholder engagement and cross-functional collaboration.
Karlyn holds a BA in Economics from Stanford University, an MBA from the Wharton School, University of Pennsylvania and an MA in International Affairs from Johns Hopkins School of Advanced International Studies
Gavin Anderson, Partner, Debevoise & Plimpton
Gavin Anderson is based in the Hong Kong office and is a member of the firm’s Investment Funds and Investment Management Group. He has broad experience in advising sponsors and investors on a variety of issues, including fund formation, co-investment and carried interest arrangements. Mr. Anderson’s recent experience includes acting for clients such as Baring Private Equity Asia, CDH Investments, D. E. Shaw, Global Infrastructure Partners, HarbourVest, Morgan Stanley, Navis Capital Partners, Southern Capital and Quilvest. Mr. Anderson earned his B.A. (Hons) from the University of Oxford (Brasenose College) in 2000 and PgDL from the College of Law at Guildford in 2001. He graduated from the Legal Practice Course at the Oxford Institute of Legal Practice in 2002. Prior to joining Debevoise in 2006, he trained and worked as an associate at an international law firm in London.
Ralph Keitel, Principal Investment Officer, IFC
Ralph Keitel is a Principal Investment Officer in the Private Equity and Investment Funds department of the International Finance Corporation (IFC), the private sector arm of the World Bank Group. Since joining IFC in early 2006, he has been responsible as regional lead for IFC’s private equity fund activities in Eastern Europe/Russia (2006-2008), Africa (2008-2011), Latin America (2011-2014) and East Asia (since 2014).
Judith Li, Partner, Lilly Asia Ventures
Judith J. Li, is a Partner at Lilly Asia Ventures (LAV), based in Hong Kong / Shanghai and focused on early and growth stage investments across biopharmaceuticals, medical devices, and diagnostics both domestically and cross-border. Judith holds board appointments at a variety of LAV’s portfolio companies, including Crown Biosciences (6554:TT), Just Biotherapeutics, Veritas Genetics, and Nextcure. Her prior experience includes McKinsey’s New York office, hospital administration at Partners Healthcare, and co-founding an interventional nephrology medical device venture. Judith holds a B.A. in Neurobiology from Harvard and M.B.A. from Harvard Business School, and currently resides in Hong Kong, splitting her time between Hong Kong, Shanghai, and the Bay Area.
Steve Okun, ASEAN Representative, EMPEA
Steve Okun, EMPEA’s ASEAN Representative, is Founder and CEO of Singapore-based APAC Advisors, having lived and worked in Asia since 2003, most recently for global investment firm and EMPEA member, KKR, and previously, with global logistics company UPS. As KKR’s first Director of Asia Public Affairs, Mr. Okun’s responsibilities encompassed government affairs, communications, stakeholder engagement and sustainability, and in supporting such efforts for its portfolio companies. His responsibilities included KKR’s Environmental, Social and Governance (ESG) initiatives. He created and led KKR’s impact investing pro bono program in the region, a model for strategic philanthropic engagement for which KKR won Public Affairs Asia’s Gold Standard Award for Corporate Citizenship.
Andrew Ostrognai, Partner, Debevoise & Plimpton
Andrew M. Ostrognai is a corporate partner and Chair of the firm’s Private Equity practice in Asia. He is also a member of Debevoise’s Private Equity Group focusing on private equity fund formation and downstream investment in the Asia Pacific region.Mr. Ostrognai has extensive experience in forming all types of funds, from large pan-Asian buy-out funds to smaller focused sector or country-specific funds, as well as separate account programs and foreign-sponsored, RMB-denominated private equity funds. Mr. Ostrognai also has strong experience in various types of secondary transactions. Mr. Ostrognai received his B.A. in 1986 from Yale University and his J.D. in 1989 from the University of Chicago Law School.
Kurt Tong, U.S. Consul General to Hong Kong and Macau
Kurt W. Tong assumed his duties as Consul General representing the United States to Hong Kong and Macau on August 27, 2016. As Chief of Mission, Mr. Tong leads a large interagency team that cooperates with the governments of Hong Kong and Macau in a variety of areas. Those areas include expansion of trade and bilateral investment; combatting transnational crime; protection of the environment; and educational and cultural exchanges. The Consulate General also supports U.S. resident citizens and visitors and provides visa services to facilitate tourist and business travel to the United States. Mr. Tong has been a diplomat since 1990, including service at the National Security Council, and in Beijing, Seoul, Tokyo and Manila. Before joining the Foreign Service, he was an Associate with the Boston Consulting Group in Tokyo. Consul General Tong holds a B.A. from Princeton University, and speaks and reads Mandarin Chinese and Japanese.